About this item:

68 Views | 23 Downloads

Author Notes:

Anna Moore, moorea57@msu.edu

Morteza Mahmoudi, mahmou22@msu.edu

We acknowledge the support of Dr. Tony Schilmiller from Mass Spectrometry and Metabolomics Core at Michigan State University for assisting us in acquiring and interpreting the MALDI MS data. We also thank the Assay Development and Drug Discovery Core at Michigan State University for assisting in the size exclusion experiment.

Morteza Mahmoudi discloses that (i) he is a co-founder and director of the Academic Parity Movement (www.paritymovement.org), a non-profit organization dedicated to addressing academic discrimination, violence and incivility; (ii) he is a Founding Partner at Partners in Global Wound Care (PGWC); and (iii) he receives royalties/honoraria for his published books, plenary lectures, and licensed patent. The author declares no conflicts of interest.

Subjects:

Research Funding:

This work is supported by the U.S. National Institute of Diabetes and Digestive and Kidney Diseases (grant DK131417-01). Protein identification were carried out by the Proteomics Biomedicum core facility, Karolinska Institutet (https://ki.se/en/mbb/proteomics-biomedicum).

A.A.S. was supported by the Swedish Research Council (grant 2020-00687) and the Swedish Society of Medicine (grant SLS-961262, 1086 Stiftelsen Albert Nilssons forskningsfond). N.N.M was supported by a Fulbright Visiting Scholar Fellowship.

Keywords:

  • albumin
  • hydrogels
  • inflammatory pathways
  • mass spectrometry
  • non-immunogenic
  • photocurable gels
  • structural analysis
  • Anti-Inflammatory Agents
  • Biocompatible Materials
  • Humans
  • Hydrogels
  • Mass Spectrometry
  • Serum Albumin, Human

Mass Spectrometry, Structural Analysis, and Anti-Inflammatory Properties of Photo-Cross-Linked Human Albumin Hydrogels

Show all authors Show less authors

Tools:

Journal Title:

ACS Applied Bio Materials

Volume:

Volume 5, Number 6

Publisher:

, Pages 2643-2663

Type of Work:

Article | Post-print: After Peer Review

Abstract:

Albumin-based hydrogels offer unique benefits such as biodegradability and high binding affinity to various biomolecules, which make them suitable candidates for biomedical applications. Here, we report a non-immunogenic photocurable human serum-based (HSA) hydrogel synthesized by methacryloylation of human serum albumin by methacrylic anhydride (MAA). We used matrix-assisted laser desorption ionization-time-of-flight mass spectrometry, liquid chromatography-tandem mass spectrometry, as well as size exclusion chromatography to evaluate the extent of modification, hydrolytic and enzymatic degradation of methacrylated albumin macromer and its cross-linked hydrogels. The impacts of methacryloylation and cross-linking on alteration of inflammatory response and toxicity were evaluated in vitro using brain-derived HMC3 macrophages and Ex-Ovo chick chorioallantoic membrane assay. Results revealed that the lysines in HSA were the primary targets reacting with MAA, though modification of cysteine, threonine, serine, and tyrosine, with MAA was also confirmed. Both methacrylated HSA and its derived hydrogels were nontoxic and did not induce inflammatory pathways, while significantly reducing macrophage adhesion to the hydrogels; one of the key steps in the process of foreign body reaction to biomaterials. Cytokine and growth factor analysis showed that albumin-based hydrogels demonstrated anti-inflammatory response modulating cellular events in HMC3 macrophages. Ex-Ovo results also confirmed the biocompatibility of HSA macromer and hydrogels along with slight angiogenesis-modulating effects. Photocurable albumin hydrogels may be used as a non-immunogenic platform for various biomedical applications including passivation coatings.
Export to EndNote